These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7674256)

  • 1. Health related utility measurement: an introduction.
    Bakker C; van der Linden S
    J Rheumatol; 1995 Jun; 22(6):1197-9. PubMed ID: 7674256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health related utility measurement in rheumatology: an introduction.
    Bakker CH; Rutten-van Mölken M; van Doorslaer E; Bennett K; van der Linden S
    Patient Educ Couns; 1993 May; 20(2-3):145-52. PubMed ID: 8337191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient utilities in fibromyalgia and the association with other outcome measures.
    Bakker C; Rutten M; van Santen-Hoeufft M; Bolwijn P; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1995 Aug; 22(8):1536-43. PubMed ID: 7473480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility measures of health-related quality of life in patients treated for benign paroxysmal positional vertigo.
    Roberts RA; Abrams H; Sembach MK; Lister JJ; Gans RE; Chisolm TH
    Ear Hear; 2009 Jun; 30(3):369-76. PubMed ID: 19322083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma.
    Blumenschein K; Johannesson M
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):189-94. PubMed ID: 9494453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preference-based quality of life measures in people with visual impairment.
    Kymes SM; Lee BS
    Optom Vis Sci; 2007 Aug; 84(8):809-16. PubMed ID: 17700344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states.
    Brown MM; Brown GC; Sharma S; Busbee B
    Ophthalmology; 2003 Jun; 110(6):1076-81. PubMed ID: 12799229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health outcomes in economic evaluation: the QALY and utilities.
    Whitehead SJ; Ali S
    Br Med Bull; 2010; 96():5-21. PubMed ID: 21037243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of outcomes measurement in rheumatology.
    Kaplan RM
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S252-5. PubMed ID: 18095788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of anchor point on utilities for 5 common ophthalmic diseases.
    Lee BS; Kymes SM; Nease RF; Sumner W; Siegfried CJ; Gordon MO
    Ophthalmology; 2008 May; 115(5):898-903.e4. PubMed ID: 17826833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient preference quality of life measures in dermatology.
    McCombs K; Chen SC
    Dermatol Ther; 2007; 20(2):102-9. PubMed ID: 17537138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia.
    Bakker C; Rutten M; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1994 Feb; 21(2):269-74. PubMed ID: 8182636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
    Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
    Med Care; 2008 Sep; 46(9):946-53. PubMed ID: 18725849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages and limitations of utility assessment methods in rheumatoid arthritis.
    Beresniak A; Russell AS; Haraoui B; Bessette L; Bombardier C; Duru G
    J Rheumatol; 2007 Nov; 34(11):2193-200. PubMed ID: 17937471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health values of adolescents with cystic fibrosis.
    Yi MS; Britto MT; Wilmott RW; Kotagal UR; Eckman MH; Nielson DW; Kociela VL; Tsevat J
    J Pediatr; 2003 Feb; 142(2):133-40. PubMed ID: 12584533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.